Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gautam Sule

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2021
Endothelial cell-activating antibodies in COVID-19Hui Shi, Yu Zuo, Sherwin Navaz, et al.
JCI Insight|September 22, 2017
Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic targetJason S Knight, He Meng, Patrick Coit, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotideHui Shi, Alex A Gandhi, Stephanie A Smith, et al.
JCI Insight|July 15, 2021
Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotideHui Shi, Alex A Gandhi, Stephanie A Smith, et al.
Science Translational Medicine|November 3, 2020
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19Yu Zuo, Shanea K Estes, Ramadan A Ali, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Prothrombotic antiphospholipid antibodies in COVID-19Yu Zuo, Shanea K Estes, Ramadan A Ali, et al.
JCI Insight|April 1, 2025
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infectionPei-Suen Tsou, Ramadan A Ali, Chenyang Lu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2021
Endothelial cell-activating antibodies in COVID-19Hui Shi, Yu Zuo, Sherwin Navaz, et al.
JCI Insight|September 22, 2017
Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic targetJason S Knight, He Meng, Patrick Coit, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotideHui Shi, Alex A Gandhi, Stephanie A Smith, et al.
JCI Insight|July 15, 2021
Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotideHui Shi, Alex A Gandhi, Stephanie A Smith, et al.
Science Translational Medicine|November 3, 2020
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19Yu Zuo, Shanea K Estes, Ramadan A Ali, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Prothrombotic antiphospholipid antibodies in COVID-19Yu Zuo, Shanea K Estes, Ramadan A Ali, et al.
JCI Insight|April 1, 2025
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infectionPei-Suen Tsou, Ramadan A Ali, Chenyang Lu, et al.
Pageof 2